Quarterly Call Option Transactions in Xeris Biopharma Holdings, Inc. (XERS)
This table provides information about the institutional ownership of Xeris Biopharma Holdings, Inc. (XERS) during . The information is specifically focused on institutions that hold call options of Xeris Biopharma Holdings, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2022 | — | 235,500 | 0 | 235,500 | -235,500 | |||
| Q4 2022 | 33,000 | 0 | 33,000 | — | 33,000 | |||
| Q1 2023 | — | 282,700 | 0 | 282,700 | -282,700 | |||
| Q2 2023 | 304,300 | 44,400 | 348,700 | — | 348,700 | |||
| Q3 2023 | 8,200 | 0 | 8,200 | 69,600 | 0 | 69,600 | -61,400 | |
| Q4 2023 | — | 84,000 | 0 | 84,000 | -84,000 | |||
| Q1 2024 | — | 257,600 | 0 | 257,600 | -257,600 | |||
| Q2 2024 | 38,700 | 0 | 38,700 | — | 38,700 | |||
| Q3 2024 | 21,900 | 0 | 21,900 | — | 21,900 | |||
| Q4 2024 | — | 114,000 | 0 | 114,000 | -114,000 | |||
| Q1 2025 | 50,100 | 47,500 | 97,600 | — | 97,600 | |||
| Q2 2025 | 5,300 | 0 | 5,300 | 21,100 | 0 | 21,100 | -15,800 | |
| Q3 2025 | 162,100 | 25,000 | 187,100 | — | 187,100 | |||